Patents Assigned to PASITHEA THERAPEUTICS CORP.
  • Publication number: 20240279345
    Abstract: The present disclosure provides ?5?1 integrin binding agents (e.g., antibodies, including multispecific antibodies, such as bispecific antibodies) and uses thereof.
    Type: Application
    Filed: May 10, 2022
    Publication date: August 22, 2024
    Applicant: PASITHEA THERAPEUTICS CORP.
    Inventor: Lisa RYNER